Mike Sherman '88 Joins Endocyte as CFO
October 11, 2006October 11, 2006, Greencastle, Ind. - Michael A. Sherman, a 1988 graduate of DePauw University, has been appointed chief financial officer of Endocyte Inc. Based in West Lafayette, Indiana, Endocyte is a private biopharmaceutical company working to develop targeted therapy products to treat cancer.
Mike Sherman comes to his new post from Guidant Corporation, where he was vice president of finance and strategic planning and played a key role in the company's initial public offering. Prior to Guidant, he was with Eli Lilly and Company where he held positions in business development, treasury and internal audit.
"We are pleased to have Mike Sherman join Endocyte as a member of our executive team," says P. Ron Ellis, Endocyte president and CEO. "His experience and leadership at Guidant and Lilly make him an ideal fit for Endocyte. He will play a key role in helping us to identify and execute the optimal financing options for the company."
An announcement at Inside Indiana Business.com notes, "Sherman received his masters in business administration from the Amos Tuck School at Dartmouth University and graduated as a Tuck Scholar. He earned his bachelor's degree in economics from DePauw University."
Read more by clicking here.Back